Wilkinson Global Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$386K Hold
420
0.03% 46
2025
Q4
$451K Hold
420
0.03% 48
2025
Q3
$320K Hold
420
0.02% 55
2025
Q2
$327K Hold
420
0.02% 58
2025
Q1
$347K Sell
420
-21
-5% -$17.5K 0.02% 60
2024
Q4
$340K Hold
441
0.02% 64
2024
Q3
$391K Sell
441
-30
-6% -$27K 0.02% 62
2024
Q2
$426K Sell
471
-50
-10% -$40K 0.03% 63
2024
Q1
$405K Hold
521
0.03% 66
2023
Q4
$304K Sell
521
-50
-9% -$29.2K 0.02% 72
2023
Q3
$307K Buy
571
+21
+4% +$10.8K 0.02% 73
2023
Q2
$258K Buy
+550
New +$231K 0.02% 81
2023
Q1
Sell
-550
Closed -$201K 95
2022
Q4
$201K Buy
+550
New +$195K 0.02% 94

Other funds holding LLY

Wilkinson Global Asset Management's LLY Position: Q1 2026 in Review

Wilkinson Global Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 420 shares worth $386K. The position accounts for 0.03% of the portfolio, ranked #46.

Wilkinson Global Asset Management first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $451K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wilkinson Global Asset Management held 420 shares of Eli Lilly worth $386K as of Q1 2026.
  • Wilkinson Global Asset Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.03% of Wilkinson Global Asset Management's portfolio in Q1 2026, its #46 holding.
  • Wilkinson Global Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • Wilkinson Global Asset Management's Eli Lilly position peaked at $451K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wilkinson Global Asset Management's 13F filing for Q1 2026, filed 13 May 2026.